THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 20 filers reported holding THERAVANCE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $94,050 | -43.3% | 95,000 | -42.4% | 0.00% | 0.0% |
| Q2 2022 | $165,888 | -83.7% | 165,000 | -82.5% | 0.00% | -85.7% |
| Q3 2021 | $1,014,909 | -81.0% | 944,000 | -82.9% | 0.01% | -88.1% |
| Q3 2020 | $5,330,000 | -9.9% | 5,511,000 | -7.3% | 0.06% | -15.7% |
| Q2 2020 | $5,914,000 | +367.5% | 5,948,000 | +338.0% | 0.07% | +400.0% |
| Q1 2020 | $1,265,000 | +55.8% | 1,358,000 | +68.3% | 0.01% | +133.3% |
| Q4 2019 | $812,000 | -80.6% | 807,000 | -81.8% | 0.01% | -81.2% |
| Q3 2019 | $4,185,000 | +194.3% | 4,446,000 | +228.4% | 0.03% | +220.0% |
| Q2 2019 | $1,422,000 | -55.2% | 1,354,000 | -56.5% | 0.01% | -61.5% |
| Q1 2019 | $3,172,000 | -41.3% | 3,114,000 | -38.1% | 0.03% | -40.9% |
| Q4 2018 | $5,403,000 | +119.4% | 5,027,000 | +98.2% | 0.04% | +214.3% |
| Q2 2018 | $2,463,000 | +16320.0% | 2,536,000 | +18014.3% | 0.01% | – |
| Q1 2018 | $15,000 | -97.3% | 14,000 | -97.7% | 0.00% | -100.0% |
| Q2 2017 | $550,000 | +614.3% | 600,000 | +631.7% | 0.00% | – |
| Q2 2015 | $77,000 | – | 82,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 41,771 | $44,921,000 | 2.37% |
| LINDEN ADVISORS LP | 45,495,000 | $48,853,000 | 1.16% |
| BASSO CAPITAL MANAGEMENT, L.P. | 4,759,000 | $5,092,000 | 0.94% |
| SSI INVESTMENT MANAGEMENT LLC | 6,850,000 | $7,332,000 | 0.60% |
| TEALWOOD ASSET MANAGEMENT INC | 1,390,000 | $1,492,000 | 0.59% |
| Castle Creek Arbitrage, LLC | 6,070,000 | $6,516,000 | 0.48% |
| OAKTREE CAPITAL MANAGEMENT LP | 21,717,000 | $23,355,000 | 0.37% |
| AQR Arbitrage LLC | 27,018,000 | $29,055,000 | 0.34% |
| CSS LLC/IL | 5,000,000 | $5,360,000 | 0.27% |
| CQS Cayman LP | 4,150,000 | $4,469,000 | 0.21% |